Our executive management team, under the direction of seasoned industry leader Mike Wilkinson, combines many years of comprehensive experience with operational, technical, financial, and business development expertise to position Kewl for growth and success. The team has a shared commitment to industry innovation and enabling proactive diabetes management.
Our Board of Directors
The Board of Directors at Kewl Innovations is responsible for monitoring the operating performance and financial condition of the company, appointing the chief executive, overseeing the company’s adherence to corporate governance standards, approving significant transactions, and establishing the strategic direction of the company. The Board consists of 3 members and is led by our Founder and Chairman Mike Wilkinson.